Syndax Pharmaceuticals Obtains $23,961,064 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ce961ddf-31b2-405b-a093-f1ee8f55cec0 - Date
6/16/2015 - Company Name
Syndax Pharmaceuticals - Mailing Address
400 Totten Pond Road Waltham, MA 02451 USA - Company Description
Syndax Pharmaceuticals, Inc. is a Waltham, MA-based, oncology-focused biotechnology company that is building a portfolio of new oncology products to extend and improve the lives of patients by developing and commercializing novel cancer therapies in optimized, mechanistically driven combination regimens. - Website
http://www.syndax.com - Transaction Type
Venture Equity - Transaction Amount
$23,961,064 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
